Figure 4.
Time to relapse in patients treated with caplacizumab + rituximab vs patients treated with caplacizumab alone (n = 75∗). (It should be noted that all patients also received PEX and corticosteroids.) ∗Two patients were lost to follow-up in the caplacizumab + rituximab group. Capla, caplacizumab.